19 results for author:"Orfao A." in Literature citations
Results Customize
› Repeat search in UniProtKB (2)
| A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors. Vicente-Duenas C., Romero-Camarero I., Gonzalez-Herrero I., Alonso-Escudero E., Abollo-Jimenez F., Jiang X., Gutierrez N.C., Orfao A., Marin N., Villar L.M. et al. EMBO J. 31:3704-3717(2012) · Mapped (3) |
| Evaluation of chemically modified carrier proteins for developing monoclonal antibodies against a clinically relevant mutation of cKIT. Jara-Acevedo R., Gonzalez-Gonzalez M., Jara-Acevedo M., Claros J., Conde A., Lopez-Perez R., Orfao A., Fuentes M. J. Immunol. Methods 384:171-176(2012) · Mapped (5) |
| Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients. Paiva B., Gutierrez N.C., Chen X., Vidriales M.B., Montalban M.A., Rosinol L., Oriol A., Martinez-Lopez J., Mateos M.V., Lopez-Corral L. et al. Leukemia 26:1862-1869(2012) · Mapped (2) |
| CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype. Paino T., Ocio E.M., Paiva B., San-Segundo L., Garayoa M., Gutierrez N.C., Sarasquete M.E., Pandiella A., Orfao A., San Miguel J.F. Haematologica 97:1110-1114(2012) · Mapped (3) |
| Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion. Morgado J.M., Sanchez-Munoz L., Teodosio C.G., Jara-Acevedo M., Alvarez-Twose I., Matito A., Fernandez-Nunez E., Garcia-Montero A., Orfao A., Escribano L. Mod. Pathol. 25:516-521(2012) · Mapped (11) |
| An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis. Teodosio C., Garcia-Montero A.C., Jara-Acevedo M., Alvarez-Twose I., Sanchez-Munoz L., Almeida J., Morgado J.M., Matito A., Escribano L., Orfao A. Leukemia 26:951-958(2012) · Mapped (7) |
| Acute myeloid leukemia of donor origin after allogeneic stem cell transplantation from a sibling who harbors germline XPD and XRCC3 homozygous polymorphisms. Diamond H.R., Ornellas M.H., Orfao A., Gomes B.E., Campos M.M., Fernandez T.S., da Silva R.I., Alves G., Lage C., da Silva D.A. et al. J Hematol Oncol 4:39-39(2011) · Mapped (6) |
| Heme-oxygenases during erythropoiesis in K562 and human bone marrow cells. Alves L.R., Costa E.S., Sorgine M.H., Nascimento-Silva M.C., Teodosio C., Barcena P., Castro-Faria-Neto H.C., Bozza P.T., Orfao A., Oliveira P.L. et al. PLoS ONE 6:e21358-e21358(2011) · Mapped (11) |
| Bcl2 is not required for the development and maintenance of leukemia stem cells in mice. Gonzalez-Herrero I., Vicente-Duenas C., Orfao A., Flores T., Jimenez R., Cobaleda C., Sanchez-Garcia I. Carcinogenesis 31:1292-1297(2010) · Mapped (3) |
| Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cells. Caraux A., Klein B., Paiva B., Bret C., Schmitz A., Fuhler G.M., Bos N.A., Johnsen H.E., Orfao A., Perez-Andres M. Haematologica 95:1016-1020(2010) · Mapped (3) |
| Evaluation of functional single nucleotide polymorphisms of different genes coding for the immunoregulatory molecules in patients with monoclonal large granular lymphocyte lymphocytosis. Garrido P., Almeida J., Romero J.M., Canton J., Sandberg Y., Barcena P., Lima M., Langerak A.W., Orfao A., Ruiz-Cabello F. Hum. Immunol. 69:101-107(2008) · Mapped (41) |
| Decreased production of inflammatory cytokines by circulating monocytes and dendritic cells in type 2 diabetic men with atherosclerotic complications. Corrales J.J., Almeida M., Burgo R.M., Hernandez P., Miralles J.M., Orfao A. J. Diabetes Complicat. 21:41-49(2007) · Mapped (2) |
| KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Garcia-Montero A.C., Jara-Acevedo M., Teodosio C., Sanchez M.L., Nunez R., Prados A., Aldanondo I., Sanchez L., Dominguez M., Botana L.M. et al. Blood 108:2366-2372(2006) · Mapped (7) |
| Cancer development induced by graded expression of Snail in mice. Perez-Mancera P.A., Perez-Caro M., Gonzalez-Herrero I., Flores T., Orfao A., de Herreros A.G., Gutierrez-Adan A., Pintado B., Sagrera A., Sanchez-Martin M. et al. Hum. Mol. Genet. 14:3449-3461(2005) · Mapped (16) |
| CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes. Suarez L., Vidriales M.B., Garcia-Larana J., Sanz G., Moreno M.J., Lopez A., Barrena S., Martinez R., Tormo M., Palomera L. et al. Clin. Cancer Res. 10:7599-7606(2004) · Mapped (9) |
| Molecular characterization of a novel immune receptor restricted to the monocytic lineage. Aguilar H., Alvarez-Errico D., Garcia-Montero A.C., Orfao A., Sayos J., Lopez-Botet M. J. Immunol. 173:6703-6711(2004) · UniProtKB (2) · Mapped (1) |
| Quantitative analysis of bcl-2 expression in normal and leukemic human B-cell differentiation. Menendez P., Vargas A., Bueno C., Barrena S., Almeida J., De Santiago M., Lopez A., Roa S., San Miguel J.F., Orfao A. Leukemia 18:491-498(2004) · Mapped (4) |
| Zinc-finger transcription factor Slug contributes to the function of the stem cell factor c-kit signaling pathway. Perez-Losada J., Sanchez-Martin M., Rodriguez-Garcia A., Sanchez M.L., Orfao A., Flores T., Sanchez-Garcia I. Blood 100:1274-1286(2002) · Mapped (15) |
| A BCR-ABL(p190) fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous bcr product. Castellanos A., Pintado B., Weruaga E., Arevalo R., Lopez A., Orfao A., Sanchez-Garcia I. Blood 90:2168-2174(1997) · Mapped (3) |